These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6775380

  • 1. [Electrophoretic properties of the factor VIII/vW complex in liver disease (author's transl)].
    Vicente García VU, Alberca Silva I, Moraleda Jiménez JM, López Borrasca A.
    Sangre (Barc); 1980; 25(4):471-8. PubMed ID: 6775380
    [No Abstract] [Full Text] [Related]

  • 2. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH, Lämmle B, Marbet UA, Ritz R, Marbet GA, Duckert F.
    Schweiz Med Wochenschr; 1981 Oct 10; 111(41):1542-3. PubMed ID: 6797063
    [Abstract] [Full Text] [Related]

  • 3. The factor VIII complex: structure and function.
    Hoyer LW.
    Prog Clin Biol Res; 1981 Oct 10; 72():1-26. PubMed ID: 6801681
    [Abstract] [Full Text] [Related]

  • 4. Molecular biology of factor VIII/von Willebrand Factor.
    Meyer D, McKee PA, Hoyer LW, Zimmerman TS, Gralnick HR.
    Thromb Haemost; 1978 Oct 31; 40(2):245-51. PubMed ID: 310584
    [No Abstract] [Full Text] [Related]

  • 5. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR.
    J Clin Invest; 1978 Aug 31; 62(2):496-9. PubMed ID: 307560
    [Abstract] [Full Text] [Related]

  • 6. [Activity of the factor VIII complex in anemia].
    Pniejnia Olszyński W, Janczarski M.
    Acta Haematol Pol; 1982 Aug 31; 13(3-4):73-80. PubMed ID: 6820867
    [No Abstract] [Full Text] [Related]

  • 7. [Study on factor VIII complex in 106 cases of liver disease (author's transl)].
    Aihara M, Sawada Y, Kimura A, Chiba Y, Yoshida Y.
    Rinsho Ketsueki; 1980 Nov 31; 21(11):1655-63. PubMed ID: 6782276
    [No Abstract] [Full Text] [Related]

  • 8. [Von Willebrand factor activity and thrombophilic states. A review (author's transl)].
    Boneu B, Abbal M, Barret A, Fournie A, Bierme R.
    Pathol Biol (Paris); 1976 Dec 31; 24 Suppl():48-53. PubMed ID: 796810
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC, Passa P, Canivet J.
    Horm Metab Res Suppl; 1981 Dec 31; 11():55-8. PubMed ID: 6797913
    [Abstract] [Full Text] [Related]

  • 10. [Disseminated intravascular coagulation (DIC); findings in 40 patients (author's transl)].
    Ichinose A, Maruyama I, Imaguma M, Synmyozu K, Igata A.
    Nihon Naika Gakkai Zasshi; 1981 Nov 10; 70(11):1531-6. PubMed ID: 6801163
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on plasma platelet factor 4 (PF4). Part 2: The role of PF4 in experimental animals with disseminated intravascular coagulation (DIC) (author's transl)].
    Hoshiyama M, Sakuragawa N, Koike K, Zimbo C, Takahashi K.
    Rinsho Ketsueki; 1977 Jun 10; 18(6):807-13. PubMed ID: 916209
    [No Abstract] [Full Text] [Related]

  • 12. [Study of factor VIII complex in increased VIII:Ag cases].
    Iijima K, Kuranobu M, Fukuda C, Nakamura K.
    Rinsho Byori; 1986 Apr 10; 34(4):459-63. PubMed ID: 3091887
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of factor VIII expression and activity by von Willebrand factor.
    Kaufman RJ, Pipe SW.
    Thromb Haemost; 1999 Aug 10; 82(2):201-8. PubMed ID: 10605705
    [No Abstract] [Full Text] [Related]

  • 14. von Willebrand factor as a regulator of intrinsic factor X activation.
    Koppelman SJ, Koedam JA, van Wijnen M, Stern DM, Nawroth PP, Sixma JJ, Bouma BN.
    J Lab Clin Med; 1994 Apr 10; 123(4):585-93. PubMed ID: 8145007
    [Abstract] [Full Text] [Related]

  • 15. [Characterization of FVIII/VW circulating after DDAVP administration (author's transl)].
    Vicente V, Díez LF, Alberca I, San Miguel J, López Borrasca A.
    An Esp Pediatr; 1981 Jun 10; 14(6):436-43. PubMed ID: 6794404
    [Abstract] [Full Text] [Related]

  • 16. [Interactions of blood coagulation factors (author's transl)].
    Cierniewski CS, Krajewski T.
    Postepy Biochem; 1981 Jun 10; 27(1):81-105. PubMed ID: 6792614
    [No Abstract] [Full Text] [Related]

  • 17. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H, Mikami S, Okuda T, Murashima N, Takase T.
    Br J Haematol; 1977 Jun 10; 36(2):259-70. PubMed ID: 301402
    [Abstract] [Full Text] [Related]

  • 18. [Studies on rabbit factor VIII. Properties of high and low molecular weight factor VIII and their changes after DIC (author's transl)].
    Kimura N, Kakishita E, Nagai K.
    Nihon Ketsueki Gakkai Zasshi; 1981 May 10; 44(3):675-82. PubMed ID: 6800181
    [No Abstract] [Full Text] [Related]

  • 19. Studies on the haemostatic system in peripheral arterial disease. 2. Variations in factor VIII components (FVIII:C ; FVIIIR:Ag ; FVIII:WF) before and after venous occlusion.
    Dettori AG, Pini M, Megha A, Portioli D, Ponari O.
    Thromb Res; 1981 May 10; 22(5-6):559-64. PubMed ID: 6795750
    [No Abstract] [Full Text] [Related]

  • 20. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A, Maruyama I, Imaguma M, Sonoda T, Igata A.
    Rinsho Ketsueki; 1981 Aug 10; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.